Compare FDMT & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDMT | VREX |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.9M | 501.8M |
| IPO Year | 2019 | 2016 |
| Metric | FDMT | VREX |
|---|---|---|
| Price | $10.42 | $9.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $31.71 | $16.67 |
| AVG Volume (30 Days) | ★ 646.0K | 349.9K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $85,209,000.00 | ★ $811,000,000.00 |
| Revenue This Year | N/A | $5.35 |
| Revenue Next Year | $70.28 | $3.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $3.03 | $6.76 |
| 52 Week High | $12.34 | $14.57 |
| Indicator | FDMT | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 57.81 | 34.77 |
| Support Level | $9.71 | N/A |
| Resistance Level | $10.70 | $12.44 |
| Average True Range (ATR) | 0.59 | 0.70 |
| MACD | 0.10 | -0.25 |
| Stochastic Oscillator | 66.93 | 20.92 |
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.